CANCELLED - SECTION 8
section 8
on 12 Nov 2021
Last Applicant/ Owned by
C/O TARO PHARMACEUTICALS U.S.A., INC.
HAWTHORNE
NY
10532
Serial Number
75683731 filed on 16th Apr 1999
Registration Number
2329449 registered on 14th Mar 2000
Correspondent Address
Kathryn Jones, Esq.
Ranbaxy Inc., a Sun Pharma Company
Intellectual Property Dept.
600 College Road East, Suite 2100
Princeton NJ 08540
Filing Basis
1. use application currently
Disclaimer
NO DATA
LUSTRA
DERMATOLOGICAL PREPARATION FOR USE IN THE TREATMENT OF HYPERPIGMENTATION, MELASMA, AND UNEVEN PIGMENTATION
Classification Information
Class [005]
Pharmaceutical Products
DERMATOLOGICAL PREPARATION FOR USE IN THE TREATMENT OF HYPERPIGMENTATION, MELASMA, AND UNEVEN PIGMENTATION
First Use Date in General
28th Feb 1998
First Use Date in Commerce
28th Feb 1998
Mark Details
Serial Number
No 75683731
Mark Type
No Service/Collective Mark
Attorney Docket Number
No TTM-050
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.11.20 -
Rectangles inside another rectangle
26.11.21 -
Rectangles that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Nov 2021 | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 |
| 14th Mar 2019 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 12th Nov 2015 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 12th Nov 2015 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 09th May 2012 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 27th Feb 2010 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
| 27th Feb 2010 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
| 24th Feb 2010 | PAPER RECEIVED |
| 24th Feb 2010 | REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED |
| 19th Dec 2007 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |